early detection
New York State DOH Approves Castle Biosciences' Barrett’s Esophagus Test
The TissueCypher assay is designed to identify patients with Barrett's esophagus who are at risk of progressing to esophageal cancer.
Investigators are trialing methods to boost sensitivity for certain cancers, and assessing measures of how tests may impact clinical care in certain screening subpopulations.
BioNexus Gene Lab, Shenzhen Rongguang Team up on Cancer Screening, Precision Medicine Programs
The organizations will work together to develop technologies and processes related to early cancer screening, preventive care, and precision medicine.
Cancer Diagnostics Firm Syantra Raises $3.6M in Series A-1 Round
The University of Calgary spinout aims to commercialize a liquid biopsy test that measures mRNA biomarkers for the early detection of breast cancer.
Lucid Diagnostics Partners With Front Line Mobile to Promote Esophageal Cancer Test
Working with the first responder medical care provider, Lucid is planning high-volume testing events among firefighters and other frontline workers with elevated risk.